Irinotecan/capecitabine versus cisplatin/capecitabine in advanced adenocarcinoma of the stomach or gastroesophageal junction: Interimsanalysis of a german AIO phase II study

被引：0
|
作者：
Moehler, M.
Kanzler, S.
Geissler, M.
Raedle, J.
Ebert, M.
Scherubl, H.
Flieger, D.
Seufferlein, T.
Galle, P. R.
Hoehler, T.
机构：
[1] Univ Mainz, Dept Med 1, D-6500 Mainz, Germany
[2] Univ Freiburg, Dept Med, D-7800 Freiburg, Germany
[3] Univ Homburg, Dept Med, D-6650 Homburg, Germany
[4] Univ Magdeburg, Dept Med, D-39106 Magdeburg, Germany
[5] Dept Med, Berlin, Germany
[6] Klinikum Aschaffenburg, Dept Med, Aschaffenburg, Germany
[7] Univ Ulm, Dept Med, D-89069 Ulm, Germany
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：313 / 313
页数：1
相关论文
共 50 条
  • [1] Irinotecan/capecitabine versus cisplatin/capecitabine in advanced adenocarcinoma of the stomach or gastroesophageal junction: Interimsanalysis of a randomized German AIO phase II study
    Moehler, M.
    Kanzler, S.
    Geissler, M.
    Raedle, J.
    Ebert, M.
    Scherubl, H.
    Flieger, D.
    Seufferlein, T.
    Galle, P.
    Hoehler, T.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 19 - 19
  • [2] Irinotecan/capecitabine versus cisplatin/capecitabine in advanced adenocarcinoma of the stomach or gastroesophageal junction: Interim analysis of a randomized German AIO phase II study.
    Moehler, M.
    Kanzler, S.
    Geissler, M.
    Raedle, J.
    Ebert, M.
    Scherubl, H.
    Flieger, D.
    Seufferlein, T.
    Galle, P. R.
    Hoehler, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 186S - 186S
  • [3] Irinotecan/capecitabine versus cisplatin/capecitabine in advanced or metastatic adenocarcinorna of the stomach or gastroesophageal junction:: Preliminary results of a randomized German AlO phase II-study
    Möhler, M
    Geissler, M
    Kanzler, S
    Raedle, J
    Ebert, M
    Fischbach, W
    Scheruebl, H
    Seufferlein, T
    Galle, PR
    Hoehler, T
    [J]. MEDIZINISCHE KLINIK, 2006, 101 (04) : A44 - A44
  • [4] A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction
    Moehler, M.
    Kanzler, S.
    Geissler, M.
    Raedle, J.
    Ebert, M. P.
    Daum, S.
    Flieger, D.
    Seufferlein, T.
    Galle, P. R.
    Hoehler, T.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (01) : 71 - 77
  • [5] A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma
    Burge, ME
    Smith, D
    Topham, C
    Jackson, DP
    Anthoney, DA
    Halstead, F
    Seymour, MT
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (09) : 1281 - 1286
  • [6] A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma
    M E Burge
    D Smith
    C Topham
    D P Jackson
    D A Anthoney
    F Halstead
    M T Seymour
    [J]. British Journal of Cancer, 2006, 94 : 1281 - 1286
  • [7] Docetaxel, cisplatin, and capecitabine (DCX) as perioperative chemotherapy in gastroesophageal adenocarcinoma: A phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
    Thuss-Patience, P. C.
    Kneba, M.
    Hofheinz, R.
    Arnold, D.
    Florschuetz, A.
    Daum, S.
    Kretzschmar, A.
    Mantovani-Loeffler, L.
    Bichev, D.
    Schumacher, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Perioperative chemotherapy with docetaxel, cisplatin, and capecitabine (DCX) in gastroesophageal adenocarcinoma: A phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
    Thuss-Patience, P. C.
    Hofheinz, R.
    Arnold, D.
    Florschuetz, A.
    Daum, S.
    Kretzschmar, A.
    Mantovani-Loeffler, L.
    Bichev, D.
    Gahn, B.
    Schumacher, G.
    Kneba, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma
    Brell, Joanna M.
    Krishnamurthi, Smitha S.
    Javle, Milind
    Saltzman, Joel
    Wollner, Ira
    Pelley, Robert
    Dowlati, Afshin
    Kantharaj, Belagodu N.
    Schluchter, Mark D.
    Rath, Linda
    Ivy, S. Percy
    Remick, Scot C.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (05) : 851 - 857
  • [10] A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma
    Joanna M. Brell
    Smitha S. Krishnamurthi
    Milind Javle
    Joel Saltzman
    Ira Wollner
    Robert Pelley
    Afshin Dowlati
    Belagodu N. Kantharaj
    Mark D. Schluchter
    Linda Rath
    S. Percy Ivy
    Scot C. Remick
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 63
12345